|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3250600 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15719675.9 |
| Date of filing the European patent application | 2015-04-27 | |
| (97) | Date of publication of the European application | 2017-12-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-06 |
| (46) | Date of publication of the claims translation | 2020-07-27 |
| (86) | Number | PCT/EP2015/059095 |
| Date | 2015-04-27 |
| (87) | Number | WO 2016/119909 |
| Date | 2016-08-04 |
| (30) | Number | Date | Country code |
| 201501613 | 2015-01-30 | GB |
| (72) |
OLIVER, Ruth, GB
ZAMACONA, Miren, GB
|
| (73) |
Biogen MA Inc.,
225 Binney Street, Cambridge, MA 02142,
US
UCB Biopharma SRL, Allée de la Recherche 60, 1070 Brussels, BE |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Autoimuninių sutrikimų gydymas CD154 antikūnais |
| TREATMENT OF AUTOIMMUNE DISORDERS WITH CD154 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 12 | 289.00 EUR |
| 2027-04-27 |